(Q43223369)

16 November 2017

Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias (English)

1 reference

16 November 2017

Hagop Kantarjian

1 reference

16 November 2017

Srdan Verstovsek

1 reference

16 November 2017

Maher Albitar

1 reference

16 November 2017

Chen-Hsiung Yeh

1 reference

16 November 2017

Wanlong Ma

1 reference

16 November 2017

Xi Zhang

series ordinal

1 reference

16 November 2017

Zhong J Zhang

series ordinal

1 reference

16 November 2017

12 December 2008

1 reference

The Journal of Molecular Diagnostics

16 November 2017

1 reference

16 November 2017

1 reference

16 November 2017

1 reference

16 November 2017

49-53

1 reference

Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2.

16 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

A role for JAK2 mutations in myeloproliferative diseases

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

A gain-of-function mutation of JAK2 in myeloproliferative disorders

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Higher detection rate of JAK2 mutation using plasma.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2607565

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19074595

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tyrosine kinases as targets for cancer therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19074595

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2353/JMOLDX.2009.080114

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

19074595

1 reference